More extensive genetic alterations in unmutated than in hypermutated cases of chronic lymphocytic leukemia

被引:15
作者
Karhu, R
Tobin, G
Thunberg, U
Vilpo, L
Sundström, C
Knuutila, S
Rosenquist, R
Vilpo, J
机构
[1] Univ Helsinki, Cent Hosp, Jorvi Hosp, Lab, FIN-02740 Espoo, Finland
[2] Univ Tampere, Canc Genet Lab, FIN-33101 Tampere, Finland
[3] Tampere Univ Hosp, Tampere, Finland
[4] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden
[5] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden
[6] Univ Tampere, Tampere Univ Hosp, Dept Clin Chem, FIN-33101 Tampere, Finland
[7] Univ Helsinki, Haartman Inst, Dept Med Genet, Helsinki, Finland
[8] Helsinki Univ Hosp, FIN-00170 Helsinki, Finland
关键词
D O I
10.1002/gcc.10227
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B-cell chronic lymphocytic leukemia (CLL) is not a uniform disease entity; approximately half of the CLL cases have undergone immunoglobulin V-H gene hypermutation, whereas the other half display unmutated V-H genes. We investigated genome changes in 12 hypermutated cases (M-CLL) and 22 unmutated cases (UM-CLL) by use of comparative genomic hybridization, G-banding, and multicolor fluorescence in situ hybridization (m-FISH) after optimal mitogen stimulation and FISH analysis of typical CLL aberrations: 11q deletion, 13q deletion, and trisomy 12. Very high frequencies of aberrations were found in both groups: 82% in UM-CLL and 83% in M-CLL. Deletions of 11q and 13q were equally distributed in M-CLL and UM-CLL. However, larger aberrations detectable by CGH, trisomy 12, and complex aberrations were less frequent in M-CLL than in UM-CLL. These observations led to a hypothesis that unmutated and mutated CLL have different biological backgrounds, given that large and/or complex chromosomal aberrations and hypermutation of the CLL progenitor cells tend to be mutually exclusive. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:417 / 420
页数:4
相关论文
共 18 条
  • [1] Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
    Damle, RN
    Wasil, T
    Fais, F
    Ghiotto, F
    Valetto, A
    Allen, SL
    Buchbinder, A
    Budman, D
    Dittmar, K
    Kolitz, J
    Lichtman, SM
    Schulman, P
    Vinciguerra, VP
    Rai, KR
    Ferrarini, M
    Chiorazzi, N
    [J]. BLOOD, 1999, 94 (06) : 1840 - 1847
  • [2] Dyer MJS, 2002, LEUKEMIA, V16, P973, DOI 10.1038/sj.leu.2402528
  • [3] Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia
    Hamblin, TJ
    Davis, Z
    Gardiner, A
    Oscier, DG
    Stevenson, FK
    [J]. BLOOD, 1999, 94 (06) : 1848 - 1854
  • [4] CHROMOSOME-ABERRATIONS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - PATHOGENETIC AND CLINICAL IMPLICATIONS
    JULIUSSON, G
    GAHRTON, G
    [J]. CANCER GENETICS AND CYTOGENETICS, 1990, 45 (02) : 143 - 160
  • [5] OPTIMIZING COMPARATIVE GENOMIC HYBRIDIZATION FOR ANALYSIS OF DNA-SEQUENCE COPY NUMBER CHANGES IN SOLID TUMORS
    KALLIONIEMI, OP
    KALLIONIEMI, A
    PIPER, J
    ISOLA, J
    WALDMAN, FM
    GRAY, JW
    PINKEL, D
    [J]. GENES CHROMOSOMES & CANCER, 1994, 10 (04) : 231 - 243
  • [6] Cryopreserved chronic lymphocytic leukemia cells analyzed by multicolor fluorescence in situ hybridization after optimized mitogen stimulation
    Karhu, R
    Vilpo, L
    Isola, J
    Knuutila, S
    Vilpo, J
    [J]. GENES CHROMOSOMES & CANCER, 2002, 34 (03) : 345 - 348
  • [7] Karhu R, 1997, GENE CHROMOSOME CANC, V19, P286, DOI 10.1002/(SICI)1098-2264(199708)19:4<286::AID-GCC12>3.0.CO
  • [8] 2-E
  • [9] Relationships of in vitro sensitivities tested with nine drugs and two types of irradiation in chronic lymphocytic leukemia
    Kivekäs, I
    Vilpo, L
    Vilpo, J
    [J]. LEUKEMIA RESEARCH, 2002, 26 (11) : 1035 - 1041
  • [10] Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: significance for cytogenetic analysis
    Larramendy, ML
    Siitonen, SM
    Zhu, Y
    Hurme, M
    Vilpo, L
    Vilpo, JA
    Knuutila, S
    [J]. CYTOGENETICS AND CELL GENETICS, 1998, 82 (3-4): : 215 - 221